Picture of Vicore Pharma Holding AB logo

VICO — Vicore Pharma Holding AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Vicore Announces FDA Breakthrough Device Designation For AlmeeTM

March 19 (Reuters) - Vicore Pharma Holding AB
 VICOR.ST :
    * VICORE ANNOUNCES FDA BREAKTHROUGH DEVICE DESIGNATION FOR
ALMEETM, A DIGITAL THERAPY FOR PATIENTS WITH PULMONARY FIBROSIS
    * PLANS TO PRESENT ALMEE AND COMPANION STUDY AT A
PULMONOLOGY
CONFERENCE IN 2024

Source text for Eikon:  ID:nMFNbqynG2 
Further company coverage:  VICOR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))

Recent news on Vicore Pharma Holding AB

See all news